Skip to main content Skip to main navigation menu Skip to site footer
Rheumatology Reports

eISSN 2036-752X

  • Archives
  • Login
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Iguratimod (T-614): A novel disease modifying anti-rheumatic drug

    Keiichi Tanaka
    e4
    23-07-2009
    https://doi.org/10.4081/rr.2009.e4
    5031
    PDF: 1363
    HTML: 35032
  • Role of calcitonin in management of musculoskeletal pain

    Lars Arendt-Nielsen, Hans Christian Hoeck, Morten A Karsdal, Claus Christiansen
    e12
    10-12-2009
    https://doi.org/10.4081/rr.2009.e12
    1754
    PDF: 903
    HTML: 3141
  • Long term efficacy and safety of a combined low and high molecular weight hyaluronic acid in the treatment of osteoarthritis of the knee

    Robert J. Petrella, Joseph Decaria, Michael Petrella
    e4
    23-03-2011
    https://doi.org/10.4081/rr.2011.e4
    7342
    PDF: 1846
    HTML: 4555
  • Biomarkers of outcome in rheumatoid arthritis

    Roberto Carrasco, Anne Barton
    e3
    02-09-2010
    https://doi.org/10.4081/rr.2010.e3
    7654
    PDF: 930
    HTML: 21702
1 - 4 of 4 items
  • Atypical femur fractures associated with bisphosphonates: from prodrome to resolution
    115
  • ANCA-associated vasculitis in scleroderma: a case series of fourteen patients
    27
  • Iguratimod (T-614): A novel disease modifying anti-rheumatic drug
    23
  • Rotator cuff disease – basics of diagnosis and treatment
    19
  • Behçet’s disease: an update on pathogenesis, diagnosis and management of vascular involvement
    18

Keywords

Rheumatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

pISSN: 2036-7511
eISSN: 2036-752X

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.